-- 周二,澳大利亚股市有望上涨,此前由于中东紧张局势升级,石油市场受到冲击,美国正采取措施限制霍尔木兹海峡的航运。 美国总统特朗普表示,伊朗已主动联系美国,希望重启谈判。此前,周末在巴基斯坦伊斯兰堡举行的会谈以失败告终。投资者正在权衡全球能源供应进一步中断的风险。 隔夜,标普500指数、纳斯达克综合指数和道琼斯工业平均指数分别上涨1%、1.2%和0.6%。 澳大利亚联邦银行(ASX:CBA)周一发布的报告显示,在宏观经济方面,澳大利亚3月份季度工资增长0.8%,新增就业岗位约2.3万个,表明劳动力市场稳定但逐渐降温,工资增长已趋于稳定在一个新的基准线附近。 企业新闻方面,澳航(ASX:QAN)预计,由于2月份航空煤油炼油利润率达到每桶约120美元的峰值,其2026财年下半年的燃油成本将达到31亿至33亿澳元。 西太平洋银行(ASX:WBC,NZE:WBC)将提高对能源密集型行业客户的信贷拨备,原因是中东冲突造成的经济波动和不确定性。 澳大利亚基准股指周一下跌0.4%,或34.6点,收于8926点。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.